Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Giles, G. G.
Right arrow Articles by Amos, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giles, G. G.
Right arrow Articles by Amos, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:1209-1211, 2003
© 2003 European Society for Medical Oncology

Original Paper

Evaluation of the organised mammographic screening programme in Australia

G. G. Giles1,+ and A. Amos2

1 Cancer Epidemiology Centre, Cancer Council Victoria, Carlton South, Victoria; 2 Breast Screen Victoria Inc., Carlton South, Victoria, Australia

Received 18 July 2002; accepted 3 April 2003

An organised approach to mammographic screening in Australia commenced in 1992 as a free service for asymptomatic women in the target age range 50–69 years and accessible to all women aged >=40 years. Screening is performed by two-view mammography, women aged 50–69 years being sent reminders every 2 years for repeat screens. National Accreditation Standards have been agreed and BreastScreen Australia has developed mechanisms to monitor and report performance including systems and standards for data collection. The national report includes participation rates, small cancer detection rates and programme sensitivities. These indicate that BreastScreen Australia is meeting its accreditation standards with respect to most measures. Routinely collected outcome data reflect an increasing trend in the proportion of women receiving breast conserving surgery; a decline in the proportion of women diagnosed with ductal carcinoma in situ undergoing axillary dissection and an increasing use of combination therapies with a corresponding decrease in the use of hormonal therapy alone. There have been increases in breast cancer incidence and falls in mortality with the largest changes in women aged 50–69 years. As the BreastScreen Australia database is routinely linked in future to population cancer registries, the mortality reduction due to mammographic screening may be estimated more precisely.

Key words: Australia, mammographic screening


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BMJHome page
K. J. Jorgensen and P. C Gotzsche
Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends
BMJ, July 9, 2009; 339(jul09_1): b2587 - b2587.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
P. Boyle
Global summit on mammographic screening
Ann. Onc., August 1, 2003; 14(8): 1159 - 1160.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.